Meta (META) CPO granted new RSUs and price-based stock options
Rhea-AI Filing Summary
Meta Platforms’ Chief Product Officer Christopher K. Cox received new equity awards as compensation. On March 20, 2026, he was granted 79,324 Restricted Stock Units, each convertible into one share of Class A common stock. These RSUs vest in 16 quarterly installments starting on May 15, 2026, contingent on continued service.
On the same date he was also granted several stock option tranches to buy Class A shares, including 12,806 options at an exercise price of $1,116.08 per share and additional tranches at exercise prices up to $3,727.12 per share, all expiring on March 19, 2031. The options vest based on Meta’s share price meeting or exceeding each tranche’s exercise price during a “Price Vesting Period” through February 14, 2028, with remaining unvested options then vesting on a set schedule through August 15, 2030, subject to Cox’s continued service. These are awards, not open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units (RSU) (Class A) | 79,324 | $0.00 | -- |
| Grant/Award | Stock Options (right to buy) | 12,806 | $0.00 | -- |
| Grant/Award | Stock Options (right to buy) | 18,066 | $0.00 | -- |
| Grant/Award | Stock Options (right to buy) | 29,340 | $0.00 | -- |
| Grant/Award | Stock Options (right to buy) | 97,541 | $0.00 | -- |
| Grant/Award | Stock Options (right to buy) | 155,491 | $0.00 | -- |
| Grant/Award | Stock Options (right to buy) | 249,382 | $0.00 | -- |
| Grant/Award | Stock Options (right to buy) | 91,239 | $0.00 | -- |
Footnotes (1)
- Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement. The RSUs vest quarterly as to 1/16th of the total RSUs, beginning on May 15, 2026, subject to continued service through each vesting date. The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date. Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.